Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Antoniou

Showing results (251-260 of 395) with videos related to

Pageof 40
Sort By:
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
JAMIA Open|October 27, 2025
Implementing integrated genomic risk assessments for breast cancer: lessons learned from the Electronic Medical Records and Genomics studyCong Liu, Katherine D Crew, Jennifer Morse, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Implementing Integrated Genomic Risk Assessments for Breast Cancer: Lessons Learned from the eMERGE StudyCong Liu, Katherine Crew, Jennifer Morse, et al.
Journal of the National Cancer Institute|June 27, 2023
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiationMark van Barele, Delal Akdeniz, Bernadette A M Heemskerk-Gerritsen, et al.
Nature Genetics|August 9, 2011
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Clare Turnbull, Emma Ramsay, et al.
Breast Cancer Research and Treatment|September 27, 2012
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriersKristen N Stevens, Xianshu Wang, Zachary Fredericksen, et al.
Nature|March 11, 2021
Improving reporting standards for polygenic scores in risk prediction studiesHannah Wand, Samuel A Lambert, Cecelia Tamburro, et al.
European Journal of Human Genetics : EJHG|August 24, 2018
Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriersKelly-Anne Phillips, Roger L Milne, Matti A Rookus, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Pageof 40

Showing results (251-260 of 395) with videos related to

Sort By:
Pageof 40
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
JAMIA Open|October 27, 2025
Implementing integrated genomic risk assessments for breast cancer: lessons learned from the Electronic Medical Records and Genomics studyCong Liu, Katherine D Crew, Jennifer Morse, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Implementing Integrated Genomic Risk Assessments for Breast Cancer: Lessons Learned from the eMERGE StudyCong Liu, Katherine Crew, Jennifer Morse, et al.
Journal of the National Cancer Institute|June 27, 2023
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiationMark van Barele, Delal Akdeniz, Bernadette A M Heemskerk-Gerritsen, et al.
Nature Genetics|August 9, 2011
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Clare Turnbull, Emma Ramsay, et al.
Breast Cancer Research and Treatment|September 27, 2012
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriersKristen N Stevens, Xianshu Wang, Zachary Fredericksen, et al.
Nature|March 11, 2021
Improving reporting standards for polygenic scores in risk prediction studiesHannah Wand, Samuel A Lambert, Cecelia Tamburro, et al.
European Journal of Human Genetics : EJHG|August 24, 2018
Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriersLogan C Walker, Louise Marquart, John F Pearson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriersKelly-Anne Phillips, Roger L Milne, Matti A Rookus, et al.
NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.
Pageof 40